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WHAT THIS PAPER ADDS
Several studies have reported results of TEVAR for complicated acute type B aortic dissections (c-ABAD).
However, the term “complicated” brings together a large range of clinical presentations and indications, from
the most dreaded rupture, to softer ones such as unrelenting chest pain or rapid aneurysmal enlargement. The
aim of this study is to assess the short- and mid-term results of endovascular stent graft management of acute
type B aortic dissections complicated by rupture.
Objective: Reports of thoracic endovascular aortic repair (TEVAR) for complicated acute type B aortic dissection
(ABAD) bring together a large range of clinical presentations.With a 30 day mortality of 50% when managed with
open surgery, rupture is the most devastating complication of ABAD. This study investigated the outcome of
TEVAR for ABAD complicated by rupture (r-ABAD) to assess the results of this particularly critical subgroup.
Methods: A review of consecutive TEVAR for r-ABAD in two tertiary referral centers was performed using a
prospectively maintained database.
Results: Between 2000 and 2013, 24 patients (mean age 71 years; 14 males) underwent TEVAR for r-ABAD.
Sixteen (67%) were in shock (Systolic blood pressure <80 mmHg) before surgery. Seven patients had coverage of
the left subclavian artery, of whom four had partial arch debranching procedures via cervical access concomitant
with TEVAR. Median length of aortic coverage was 150 mm, median proximal oversizing was 13.3% (range 6.2e
33.3%). Technical success was achieved in 100%. There were four in hospital deaths (16%). Two patients (8%) had
paraplegia, but neither stroke nor renal insufﬁciency requiring dialysis occurred. During a mean follow up of 28
months, there was one aortic dissection related death and eight patients (40% of the surviving patients) required
re-intervention. All re-interventions were managed endovascularly. At last follow up CT scan, eight patients (40%)
had complete remodeling of the aortic wall.
Conclusion: With 16% in hospital mortality and 8% early major complications, this study conﬁrms the feasibility
of TEVAR for r-ABAD with a lower peri-operative morbidity and mortality rate compared with open surgery. Given
the high rate of re-intervention, close follow up is required in surviving patients.
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INTRODUCTION
Several studies have reported results of TEVAR for compli-
cated acute type B aortic dissections (c-ABAD).1e3 Covering
the proximal tear by a stent graft reduces or prevents ﬂow
in the false lumen and thereby allows true lumen expan-
sion. As a consequence of lower peri-operative morbidity
and mortality compared with open surgery, TEVAR is now
considered as ﬁrst line therapy for c-ABAD.1e3 However, the
term “complicated” brings together a large range of clinical
presentations and indications, from the most dreaded
rupture, to softer ones such as unrelenting chest pain or
rapid aneurysmal enlargement.
In the setting of rupture, TEVAR is usually performed
as an emergent procedure, using off the shelf stent grafts
which are not always the most appropriate. In addition,
in the setting of this speciﬁc complication, questions
remain about the role and length of the stent graft: is
coverage of the proximal entry tear sufﬁcient only to
stop bleeding or should the stent graft cover the
entire dissected aorta with the increased risk of
paraplegia?4,5
The aim of this study is to assess the short- and mid-term
results of endovascular stent graft management of acute
type B aortic dissections complicated by rupture.
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PATIENTS AND METHODS
The ethical committee of the hospital approved this study.
Patients’ selection and follow up
This study is a retrospective analysis of two tertiary referral
centers’ prospective registries of TEVAR for ruptured acute
type B aortic dissection. The patients were enrolled be-
tween October 2000 and December 2013. Aortic dissection
was deﬁned as acute within 14 days of the onset of acute
symptoms. Aortic rupture was deﬁned as disruption of the
aortic wall with concomitant extravasation of fresh blood
outside the adventitia of the thoracic aorta or concomitant
hemothorax, as documented by pre-operative computed
tomography (CT). Patients who did not respond to initial
emergency department treatment and had recurrent hy-
potension (systolic blood pressure <80 mmHg) despite
adequate ﬂuid challenges were deﬁned as in shock. Once
the shock was treated, controlled hypotension was main-
tained with a systolic blood pressure between 80 and
90 mmHg, in order to reduce the risk of additional bleeding.
According to the Reporting Standards For Thoracic
Endovascular Aortic Repair, technical success was deﬁned as
complete coverage of the primary entry tear without type 1
leak or persistent extravasation of fresh blood outside the
adventitia of the thoracic aorta at the end of the procedure.
Patients were evaluated with respect to pre-operative
age, gender, smoking, obesity, hypertension, diabetes,
long-term anticoagulant therapy, renal insufﬁciency, history
of ascending or abdominal aortic repair, and according to
the American Society of Anesthesiologist (ASA) classiﬁca-
tion. They were prospectively followed up by scheduled
clinical observation and by contrast enhanced CT pre-
operatively, before hospital discharge, at 1, 3, 6, and 12
months, and annually thereafter.
All aortic CTmeasurements were taken in a perpendicular
plane using center line reconstructions. Pre- and post-
operative measures included neck diameter and length for
device sizing, maximal aortic diameter. Extension of the
dissection above or below the celiac axis, false lumen status
at the level of the stent and more distally were also analyzed.
Endovascular device and procedural details
All endovascular procedures were performed in an oper-
ating theater under general anesthesia. Open femoral cut
downs were used to facilitate catheter based access to the
true lumen and the aortic arch.
Transesophageal echocardiography was performed to
assess the position of the guide wire in the true lumen
before deployment of the stent graft and after deployment
to ensure entry tear and aortic rupture sealing, false lumen
thrombosis, and absence of endoleak. Angiograms were
performed before stent graft deployment to clearly delin-
eate the proximal tear site and, if possible the rupture site,
and after deployment to conﬁrm entry tear and aortic
rupture sealing and absence of endoleak. For patients with
a short proximal landing zone (<20 mm), coverage of the
left subclavian artery without revascularization was usually
performed. In cases of stable patients with short proximal
landing zone, hybrid operations, combining extra-anatomic
debranching of the supra-aortic vessels with immediate
endovascular stent graft deployment, were performed on a
case by case basis.
Over the period of study inclusion, ﬁve different stent
grafts were used: the Excluder stent graft (W.L. Gore and
Associates, Flagstaff, AZ, USA); the TAG stent graft (Gore);
the Talent (Medtronic, Sunrise, FL, USA); the Valiant devices
(Medtronic) and the Zenith TX2 stent graft (Cook Bloo-
mington, IN, USA). Stent graft selection was at the discre-
tion of the surgeon and according to availability at the time.
Length of aortic coverage depended on the location of the
aortic rupture on pre-operative CT scan or on the intra-
operative angiogram if seen, or according to the surgeon
preference.
Cerebrospinal ﬂuid drainage to prevent spinal cord
ischemia was not used in these emergent cases.
Statistical analysis
Continuous variables are expressed as means and standard
deviation. For group comparison the appropriate t tests and F
tests were utilized; p values <.05 were considered statisti-
cally signiﬁcant. All statistical analyses were performed at the
Clinical Research and Epidemiology Department of the CHU
Montpellier with SAS 9 (SAS Institute Inc, Cary, NC, USA).
RESULTS
Patient demographics
Between October 2000 and December 2013, 24 patients
underwent stent graft placement for r-ABAD. Patient char-
acteristics are reported in Table 1. The median age of the
patients was 71 years (range 44e82) with a male to female
ratio of 1.4:1. One patient (4%) had had prior aortic surgery
including composite graft replacement of the aortic valve,
aortic root, and ascending aorta, with re-implantation of the
coronary arteries into the graft (Bentall procedure).
Twenty patients (83%) presented with a left hemothorax
on the pre-operative CT scan and had chest drainage after
stent graft placement. Three patients (13%) had peri-aortic
blood extravasation but no frank hemothorax, and one
Table 1. Clinical characteristics of the patients.
Clinical characteristicsa N ¼ 24
Age, years 68  11
Male sex 14 (58)
Hypertension 20 (83)
Diabetes 1 (4)
Smoker 9 (37.5)
Coronary artery disease 2 (8)
Moderate renal insufﬁciency 3 (12.5)
Prior aortic surgery 1 (4)
Marfan 0 (0)
ASA II 4 (17)
ASA III 8 (33)
ASA IV 12 (50)
a Continuous data are shown as mean  standard deviation and
categoric data as number (%).
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patient (4%) had a massive hemoptysis caused by an aorto-
bronchial ﬁstula. Sixteen patients (67%) were in shock
(recurrent systolic blood pressure <80 mmHg) before sur-
gery, requiring inotropic and/or vasopressor drugs before or
during the procedure. Two patients had cardiac arrest in the
operative room during the induction of general anesthesia
with successful external cardiac massage.
The dissection extended to the abdominal aorta in 21
patients (87.5%), and was restricted to the thoracic aorta in
three patients (12.5%).
Procedural outcomes
The median interval from the onset of dissection to aortic
rupture was 4 days (range 0e14 days).
Over the period of the study, ﬁve different stent grafts
were implanted: the Thoracic Excluder stent graft in two
patients (8%); the TAG stent graft in 11 (46%); the Talent in
four (17%); newer generation Valiant devices in six (25%);
and the Zenith TX2 stent graft in one (4%).
Device diameters ranged from 26 to 42 mm. The mean
proximal landing zone diameter was 31.3 mm (range 22e
38 mm), median proximal oversizing was 13.3% (range 6.2e
33.3%). The mean oversizing before 2007 was 20.2%
(n ¼ 9). After 2007, the mean oversizing was 11.8%
(n ¼ 15). The median length of aortic coverage was 150 mm
(range 100e300 mm). Sixteen patients had a length of
aortic coverage 150 mm (range 100e150). All these pa-
tients had intra-operative transesophageal echocardiogra-
phy that conﬁrmed proximal entry tear and aortic rupture
sealing, false lumen thrombosis of the thoracic aorta, and
absence of endoleak after stent graft deployment.
The proximal landing zone was in zone 3 in 18 patients
(75%), in zone 2 in ﬁve (21%), and in zone 1 in one (4%). Six
(25%) patients required complete coverage of the left
subclavian artery, of whom one patient also required
coverage of left common carotid (proximal landing zone in
zone 1) for appropriate coverage of the proximal entry
tear. Among these six patients, three (50%) had revascu-
larization of the supra aortic trunk concomitant with
TEVAR: two hemodynamically stable patients at the time
of the procedure had transposition of the LSA onto the left
common carotid and the patient with proximal landing
zone in zone 1 had a hemi-arch debranching procedure via
cervical access.
Additional procedures performed in the operating room
immediately after stent graft placement included intercostal
chest tube drainage for left hemothorax in 20 patients.
There were no intra-operative complications.
Technical success deﬁned as sealing of the primary entry
tear without residual endoleak at the end of the procedure,
was achieved in all the cases. No patient required conver-
sion to open surgery.
Early results
In hospital mortality. The in hospital mortality rate was
16.7% (4/24). One patient died on the day of the procedure
from heart failure. A second died at day 4 post TEVAR. The
reason for his death remains unknown; this patient was
confused, and convulsed before surgery with a pre-operative
normal non-contrast cerebral CT scan. A third developed a
new rupture of the distal descending thoracic aorta and died
of hemorrhagic shock at day 3. He had initial successful
endovascular repair using 300 mm of stent graft aortic
coverage and a 33% oversizing. The ﬁnal patient had the
aorto-bronchial ﬁstula; he developed post-operative para-
plegia, the post-operative course was complicated by pneu-
monia and he died at day 60 froman acute respiratory distress
syndrome in the intensive care unit. This was the only late
death (>30 days) attributed to the primary TEVAR procedure.
In hospital major adverse events. Two patients (8.3%)
developed post-operative paraplegia: one (the patient
mentioned above) had coverage of the LSA without revas-
cularization and had 200 mm of aortic coverage; the second
had 250 mm of aortic coverage. Neither renal insufﬁciency
requiring dialysis, nor retrograde dissection occurred.
In hospital re-intervention. Four patients required early re-
intervention within 2 weeks of TEVAR. They were all
managed by an additional endovascular procedure and
there was no related death (Table 2).
Late outcome
The mean follow up was 28 months (range 2 months e 8
years).
Late re-intervention. Four patients required late re-
interventions, giving a total of eight re-interventions (40%
of the surviving patients). The mean delay to re-intervention
Table 2. Indication for re-intervention, type of procedure, and outcomes.
No. Etiology Time from initial
procedure
Secondary intervention Outcome
1 Distal Type I EL Day 1 Distal SG Alive
2 Prox. Type I EL Day 2 Prox. SG (LSA coverage) Alive
3 Type II EL (LSA) Day 7 Amplatzer in LSA Alive
4 Prox. Type I EL Day 13 Prox. SG (ROSA coverage) Alive
5 SG migration Month 6 Prox. SG Alive
6 Thoraco-abdominal dissecting aneurysm Year 5 Debranching of the visceral trunks þ SG Died 1 month (MODS)
7 Aneurysm of the DTA above the SG Year 5 Prox. SG (LSA transposition) Alive
8 Prox. Type I EL Year 7 Prox. SG (LSA transposition) Died 1 month (cirrhosis)
EL ¼ endoleak; SG ¼ stent graft; Prox. ¼ proximal; LSA ¼ left subclavian artery; ROSA ¼ retro-oesophageal right subclavian artery;
DTA ¼ descendant thoracic aorta; MODS ¼ multiple organ dysfunction syndrome.
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was 24.6 months (range 1 day e 7.3 years) after ﬁrst im-
plantation. The indications for early (<14 days) and late
(>14 days) re-interventions, as well as type of procedure,
are reported in Table 2.
After late re-intervention, one patient died of decom-
pensated cirrhosis at 30 days post re-intervention, and
another patient died after re-intervention for a type 4 thoraco-
abdominal aneurysm 38 days post re-intervention. He had a
hybrid procedure with transposition of the visceral trunks and
stent grafting of the thoraco-abdominal aorta. He died during
the post-operative course from multiple organ failure.
Remodeling. For all patients in the study, favorable aortic
remodeling, deﬁned as stabilization or regression of the
false lumen diameter, was demonstrated in 19 patients
(n ¼ 19/20; 95% of the surviving patients) on their last
follow up CT scans. Complete aortic remodeling, deﬁned as
complete reattachment of the dissecting membrane, was
noted in eight patients (40%).
DISCUSSION
Aortic rupture is the most catastrophic complication of
acute type B dissection leading to death without surgery.6e9
Even in the most experienced hands early open surgery is
associated with a high mortality rate from 29% to 50%, and
a high rate of major adverse events such as stroke, para-
plegia, heart failure, or respiratory insusufﬁciency.10e13
In the setting of patients with hemodynamic instability,
TEVAR allows quick control of aortic bleeding preventing
mortality or major morbidity, and the endovascular approach
for emergency aortic injury has evolved widely in recent
years.TEVAR is now considered to be the ﬁrst line therapy for
acute complicated type B aortic dissection.1e3,14,15
With 16.7% in hospital mortality and 8.3% post-operative
major adverse events, TEVAR reduces both the overall risk
for mortality and major complications compared with open
repair.16,17 However, in the setting of r-ABAD, the endovascular
procedure is confronted with speciﬁc issues and there are
important questions remaining.18 Among them, the length of
aortic coverage is not well established.4 For patients who
survived transportation to the hospital, the rupture is usually
supplied by the false lumen of the dissected thoracic aorta,
resulting in peri-aortic blood suffusion. The exact location of
the rupture is often difﬁcult to determine on CTscan or even in
the operating room with ﬂuoroscopy.4 As such, questions are
raised as to the optimal length of aortic coverage to stop
bleeding without increasing the risk of paraplegia. With
regards to the present results, it seems that in most of cases,
even if the exact location of the rupture is not precisely seen,
closing the proximal entry tear with a 150 mm long stent graft
allows false lumen thrombosis at thoracic level and is sufﬁcient
to exclude false lumen rupture and to stop bleeding. Nienaber
et al. also reported that the stent graft did not necessarily
cover the entire dissection, with an average length of aortic
coverage of 130 mm.4 However, in the present study proximal
entry tear sealing, false lumen thrombosis of the thoracic
aorta, and above all arrest of bleeding after stent graft
deployment shown by intra-operative transesophageal
echocardiography (TEE) were conﬁrmed. If one of these fac-
tors was not achieved, another stent graft was added proximal
or distal to the ﬁrst depending on the TEE ﬁndings.TEE is a very
important tool during TEVAR for r-ABAD4 and, during recent
years, TEE for stent graft placement in type B aortic dissection
has been performed systematically, even in the emergency
setting. This allows for an optimal (and usually shorter) length
of aortic coverage, rather than systematic extensive aortic
coverage. Twenty patients (83%) had TEE during the pro-
cedures that made possible a technical success of 100%,
without intra-operative death. Among the 16 patients who
had limited aortic coverage (<150 mm), none had repeated
rupture of the aorta. In contrast, two paraplegias occurred in
patients who had a greater length of aortic coverage at the
initial procedure. It is assumed that extensive aortic coverage
is not associated with a lower rate of repeated rupture of the
aorta but increases the risk of paraplegia.
One patient had early (<4 days) repeated rupture of the
aorta despite extensive aortic coverage of 300 mm, and a
sealing of the primary entry tear without residual endoleak at
the end of the procedure. However, this patient had an
excessive oversizing>30%, and it is presumed the new rupture
was caused by the stent graft inducing a new entry tear rather
than as a result of issues with length of aortic coverage.
Optimal oversizing for type B aortic dissection is still under
debate. At present, the authors performmoderate oversizing
of around 10% for type B aortic dissectionwithout rupture. In
the case of rupture the proximal aortic diameter on pre-
operative CT scan could be underestimated because of hy-
potension, so these are oversized a little more - around 12%.
In the present study, a mean proximal oversizing range from
6.2% to 33.3% is reported, which is a large. In patients treated
before 2007 the mean proximal oversizing was high (20.2%),
and higher than after 2007 (11.8%). It is important to high-
light that until 2007 the thoracic stent graft store was limited
to a few diameters; the stent graft used was not always the
optimal diameter; and excessive oversizing was more com-
mon because of unavailability of the appropriate diameter in
the emergency setting. Since 2007 awider range of diameters
is commercially available and oversizing can be done more
suitably. No retrograde dissection is reported in this study;
however, it has been reported previously that excessive
oversizing is a risk factor for retrograde dissection, for stent
graft collapse, and for re-intervention.19e21 These data
conﬁrm that emergency patients should be treated in tertiary
referral centers, which should have a large range of thoracic
stent graft sizes available from stock.
Another issue with TEVAR for r-ABAD is that the adequate
proximal landing zone is difﬁcult to locate as the entry tear is
usually in the left hemiarch. The place for transposition of the
left subclavian artery (LSA) in an emergency setting remains
unclear. Some authors have reported that in the emergency
setting there is no indication for left carotid-subclavian bypass
or transposition.18 However, coverage of the LSA is a risk factor
for paraplegia and could be fatal if the vertebral artery had a
termination into the posterior inferior cerebral artery. In the
present study, one of the two patients who had paraplegia had
intentional complete coverage of the LSA without
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revascularization. It is suggested that revascularization of the
LSA in an emergency setting should be assessed on a case by
case basis: in the case of hemodynamic instability the primary
endpoint is to stop bleeding and there is no time for subclavian
transposition. However, in the case of hemodynamically stable
patients, especiallywhen longaortic length coverage is needed,
transposition of the LSA should be considered. Moreover, two
early proximal type I endoleaks were reported in patients who
had primary intervention without coverage of the LSA. They
both had re-intervention to place additional proximal stent
grafts that could have been avoided by initial coverage of the
LSA, and it is assumed that when needed for an appropriate
proximal landing zone (>2 cm) the LSA should be covered.
In the present series, the re-intervention rate at 28
months mean follow up was 40%. The rate of re-intervention
is quite similar compared with the re-intervention rate after
TEVAR for complicated type B aortic dissection reported in
the MOTHER database.22 This high re-intervention rate can
be explained as in acute type B dissection complicated by
rupture, the planning of TEVAR is challenging for three rea-
sons:1 the proximal aortic diameter on pre-operative CT scan
can be undersized because of hypotension;2 the adequate
proximal landing zone is difﬁcult to locate as the entry tear is
usually in the left hemiarch; and3 the proper endograft size
may be unavailable in the emergency situation.
In the present series, 44% of the re-interventions were
performed in the ﬁrst 2 weeks after the primary procedure.
Early re-interventions were all performed by endovascular
means, without excess mortality. This reinforces the inten-
tion that the primary endpoint is to treat the aortic rupture
and stop bleeding with the aim of preventing mortality or
major complication of hemodynamic shock. Early (before
hospital discharge) CT scan follow up is mandatory after
emergency TEVAR. In the case of non-optimal aortic
coverage, a secondary procedure must be performed to
improve long-term results in stable patients, and should not
be considered as failure of TEVAR.5
Conclusion
With 16% in hospital mortality and 8% early major compli-
cations, TEVAR in this particular group is not without signif-
icant mortality and morbidity. However, these results are
encouraging bearing inmind the severity of this complication
and prompt consideration of TEVAR as ﬁrst line therapy.
TEVAR in this emergency setting is associated with speciﬁc
issues that must be understood to improve long-term results;
moderate oversizing (10%) should be performed and closing
only the proximal entry tear with 150 mm of length stent
graft is generally sufﬁcient to exclude false lumen rupture
and stop bleeding. Given the high rate of re-intervention,
close follow up is mandatory in surviving patients.
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At the Back of my Mind
B. Sandford *, A.R. Naylor
Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
A 59-year-oldmandeveloped sudden onset vertigo, diplopia, and vomitingwhich resolved in< 12hours.Thenext day, the same
symptoms recurred, this time in associationwith left arm and legweakness.Therewas no history of trauma, but he recalled a bout
of violent coughing 2 days earlier. A magnetic resonance imaging brain scan demonstrated an acute left cerebellar infarct with
retrograde ﬂow in the distal left vertebral artery. A computed tomography angiogram revealed an extensive left vertebral artery
dissection. This was treated with anticoagulation, with no recurrence of any focal neurological symptoms.
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